Buchumschlag

Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa

In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Michaeli, Daniel (VerfasserIn) , Stoycheva, Sophia (VerfasserIn) , Marcus, Simon Mashudu (VerfasserIn) , Zhang, Wenjia (VerfasserIn) , Michaeli, Julia (VerfasserIn) , Michaeli, Christoph T. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 March 2022
In: Clinical drug investigation
Year: 2022, Jahrgang: 42, Heft: 4, Pages: 333-343
ISSN:1179-1918
DOI:10.1007/s40261-022-01138-6
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40261-022-01138-6
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s40261-022-01138-6
Volltext
Verfasserangaben:Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, Wenjia Zhang, Julia Caroline Michaeli, Thomas Michaeli
Beschreibung
Zusammenfassung:In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from the South African healthcare system perspective.
Beschreibung:Gesehen am 19.03.2024
Beschreibung:Online Resource
ISSN:1179-1918
DOI:10.1007/s40261-022-01138-6

Ähnliche Einträge